US Stock MarketDetailed Quotes
ITCI Intra-Cellular Therapies
- 85.690
- +0.240+0.28%
Close Nov 22 16:00 ET
- 85.690
- 0.0000.00%
Post 16:48 ET
9.08BMarket Cap-98494P/E (TTM)
86.100High84.740Low437.92KVolume85.880Open85.450Pre Close37.47MTurnover0.42%Turnover RatioLossP/E (Static)106.02MShares93.45052wk High7.93P/B8.89BFloat Cap58.14052wk Low--Dividend TTM103.74MShs Float93.450Historical High--Div YieldTTM1.59%Amplitude6.750Historical Low85.566Avg Price1Lot Size
Intra-Cellular Therapies Key Stats
EPS
According to the latest financial report of Intra-Cellular Therapies, the latest earnings per share (TTM) for the company is -0.25. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Intra-Cellular Therapies's free cash flow? The latest report shows it as -27.22M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Intra-Cellular Therapies shows that the company's current ratio is 7.66, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Intra-Cellular Therapies, the quick ratio is 6.94, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Intra-Cellular Therapies? The latest ROE figure is -2.30%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Intra-Cellular Therapies, the total asset return on investment (ROA) is -1.99%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Intra-Cellular Therapies's latest financial report to see how their gross margin is doing - currently at 91.26%.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Intra-Cellular Therapies, the net profit margin is -15.01%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data